🇺🇸 FDA
Patent

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

granted A61KA61K38/06A61K45/06

Quick answer

US patent 7816324 (Composition and method for the treatment of diseases affected by a peptide receptor) held by The Board of Regents of the University of Texas System expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/06, A61K45/06, A61P, A61P3/00